Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The pruritus pathway refers to the complex network of molecular, cellular, and neural mechanisms responsible for the sensation of itch (pruritus). It involves both peripheral and central components, with multiple mediators, receptors, and signaling pathways contributing to the transmission and modulation of itch signals from the skin to the brain. Key components include primary sensory neurons, GPCRs (H1R, H4R, PAR2, PAR4), TRP channels (TRPV1, TRPA1), and cytokines (IL-4, IL-13, IL-31, TSLP). Dysregulation underlies many chronic itchy skin diseases.
Multiple, depending on the specific target within the pathway. Includes receptor antagonism (antihistamines), enzyme inhibition (JAK inhibitors), and receptor agonism (kappa opioid agonists).
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pruritus Pathway.